naa a22 4500 510741193 CHVBK 20180411083028.0 cr unu---uuuuu 180411e20131201xx s 000 0 eng 10.1007/s11845-013-0960-8 doi (NATIONALLICENCE)springer-10.1007/s11845-013-0960-8 Treatment of seborrheic dermatitis: comparison of sertaconazole 2% cream versus pimecrolimus 1% cream [Elektronische Daten] [M. Goldust, E. Rezaee, R. Raghifar] Objective: Seborrheic dermatitis (SD) is an inflammatory skin disorder affecting the scalp, face, and trunk. The treatment of SD is an important issue in dermatology. This study aimed at comparing the efficacy of sertaconazole 2% cream versus pimecrolimus 1% cream in the treatment of SD. Methods: In this clinical trial study, 60 patients suffering from SD were studied. Thirty patients received local sertaconazole 2% cream and in control group, 30 patients received pimecrolimus 1% cream. Patients were recommended to use the cream twice a day for 4weeks. At the beginning of referring and also 2 and 4weeks after first visit, the patients were examined by a dermatologist to control improvement of clinical symptoms. Results: The mean age of members of the sertaconazole and pimecrolimus groups was 30.12±12.56 and 34.67±10.98years, respectively. The highest level of satisfaction (90%) was observed 28days after sertaconazole application since it was 80% in pimecrolimus group. The relationship between patients' satisfaction and receipt of sertaconazole cream (on the 28th day) was statistically significant (P=0.006). Conclusion: Sertaconazole 2% cream may be an excellent alternative therapeutic modality for treating SD. Royal Academy of Medicine in Ireland, 2013 Seborrheic dermatitis nationallicence Sertaconazole 2% cream nationallicence Pimecrolimus 1% cream nationallicence Goldust M. Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran aut Rezaee E. Medicinal Chemistry, Shahid Beheshti University of Medical Sciences, Tabriz, Iran aut Raghifar R. Tabriz Azad University of Medical Sciences, Tabriz, Iran aut Irish Journal of Medical Science Springer London 182/4(2013-12-01), 703-706 0021-1265 182:4<703 2013 182 11845 https://doi.org/10.1007/s11845-013-0960-8 text/html Onlinezugriff via DOI 1 research-article jats NATIONALLICENCE 856 40 https://doi.org/10.1007/s11845-013-0960-8 text/html Onlinezugriff via DOI NATIONALLICENCE 700 1- Goldust M. Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran aut NATIONALLICENCE 700 1- Rezaee E. Medicinal Chemistry, Shahid Beheshti University of Medical Sciences, Tabriz, Iran aut NATIONALLICENCE 700 1- Raghifar R. Tabriz Azad University of Medical Sciences, Tabriz, Iran aut NATIONALLICENCE 773 0- Irish Journal of Medical Science Springer London 182/4(2013-12-01), 703-706 0021-1265 182:4<703 2013 182 11845 Metadata rights reserved Springer special CC-BY-NC licence nationallicence BK010053 XK010053 XK010000 NATIONALLICENCE NATIONALLICENCE NL-springer